The global drug eluting stents (DES) market size is forecast to reach USD 8.98 billion by 2026, attributable to the increasing prevalence of cardiovascular diseases worldwide. A drug eluting stent is a semi-rigid device in the form of a tube that is coated with a drug that helps to prevent reoccurrence or restenosis of an arterial blockage when released. They help to reduce restenosis cases and also limits the risk of late or early thrombosis in patients. More information on the market is provided in a recently published report by Fortune Business Insights™ titled, “Drug Eluting Stents (DES) Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Product (Polymer-based, and Polymer-free), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026.” As per this report, the market value was USD 5.71 billion in 2019 and will exhibit a CAGR of 6.7% between 2019 to 2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/drug-eluting-stent-des-market-102612

List of Significant Drug Eluting Stents (DES) Market Manufacturers are as follows:

• Abbott
• Boston Scientific Corporation
• Biotronik
• MicroPort Scientific Corporation
• Medtronic
• Terumo Corporation
• Other Players

What is the Scope of the Report?

The report offers a 360-degree overview of the market and its prime growth trajectories such as drivers, restraints, challenges, and upcoming opportunities. It also discusses the market segment based on factors such as type, scaffold, drug, end-user, and regions. It also provides market figures and CAGRs of the leading segments wit its attributed reasons. Additionally, the report throws light on current drug eluting stents market trends, key industry developments, and other interesting insights. Competitive landscape, list of players operating in the market and the strategies adopted by them to earn the leading position in the market are also listed in the report. For more information on the report, log on to the company website.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/drug-eluting-stent-des-market-102612

Market Drivers

Improving Healthcare Infrastructure in developing nations will Propel Growth

The increasing cases of cardiovascular diseases worldwide are a significant factor in boosting the global market for drug eluting stents. Besides this, government-supported reimbursement policies and a rise in expenditure on research and development of better stents are also aiding in the expansion of the market. This, coupled with the FDA approvals and CE marks received by many stents, is expected to promote the drug eluting stents market growth in the forecast period.

On the other side, the market may face challenges in terms of product recalls. Nevertheless, the introduction of technologically advanced and novel therapeutics are likely to create lucrative growth opportunities for the market in the coming years.

Regional Segmentation:

Rising Incidences of Cardiovascular Diseases will Help Asia Pacific witness Significant Growth

Currently, North America is holding the dominant drug eluting stents market share owing to the increasing prevalence of cardiovascular diseases and the supported reimbursement policies supported by governments in the region. In 2018, this region generated a revenue of USD 1.80 billion. Additionally, the increasing trend of biodegradable polymer-based drug eluting scaffolds may further help this region continue dominance in the forecast period as well. On the other side, the market in Europe will emerge as the fastest-growing region owing to the rise in the number of third-generation DES with the CE mark and the rising popularity of polymer technology for the production of stents. Furthermore, the increasing cases of cardiovascular diseases and the improving medical infrastructure and medical facilities will help Asia Pacific witness significant growth in the coming years.

The global “Contact Lenses Market Size” is projected to reach USD 12.05 billion by 2026, exhibiting a CAGR of 4.8% during the forecast period. However, the market was worth USD 8.35 billion in 2018. This information is published in a recent report by Fortune Business Insights, titled, “Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-Focal, and Spherical), By Distribution Channel (Retail Stores, Online Stores, and Ophthalmologists), and Regional Forecast, 2019-2026.” As per the report, rising per capita healthcare expenditure and increasing incidence of astigmatism and myopia are expected to affect the market positively.

Highlights of the Report:

• In-depth analysis of various insights, namely, Contact Lenses Market trends, growth drivers, opportunities, and other related challenges.
• Comprehensive details of key market players, their core competencies, and Contact Lenses Market share.
• The potency of suppliers and buyers to make better business decisions.
• Lists out the market size in terms of volume.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contact-lenses-market-101775

Key Players Operating in The Contact Lenses Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Contamac
• CooperVision
• HOYA Corporation
• Essilor
• Bausch & Lomb Incorporated
• Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
• ZEISS International
• Alcon Vision LLC
• Other key market players

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775

Rising Prevalence of Ocular Disorders to Augment Market Growth

The World Health Organization (WHO) stated that approximately 1.7 million people are affected by presbyopia and around 153 million people reside with uncorrected refractive errors around the world. A rising prevalence of presbyopia worldwide is one of the main factors propeling the contact lenses market growth in the coming years. Also, many people are affected by ocular disorders, which in turn, is expected to boost growth of the market.

Asia Pacific to Exhibit Rapid Growth Fueled by Rising Disposable Income

The contact lenses market can be geographically grouped into the Middle East & Africa, North America, Asia Pacific, Latin America, and Europe. Out of them, North America is set to dominate the market during the forecast period. It was valued at USD 2.75 billion in 2018. This growth is attributed to the rising usage of contact lenses amongst the masses as well as increasing prevalence of presbyopia. The Centers for Disease Control and Prevention (CDC) mentioned that in the U.S., around 45 million people use contact lenses.

Asia Pacific, on the other hand, is expected to remain in the second position owing to gradual inclination of the masses to disposable contact lenses from reusable contact lenses. Also, various market players are launching novel products day by day in this region. It is also giving rise to market growth. The region is projected to experience rapid growth in the coming years owing to the rising trend of wearing contact lenses amongst the youngsters for correcting vision errors. Moreover, the increasing awareness programs regarding the benefits of using contact lenses, rising disposable income, and availability of lenses on online platforms would also contribute to the demand for contact lenses in this region.

According to a report published by Fortune Business Insights, titled, “Autism Spectrum Disorder Therapeutics Market”: Global Market Analysis, Insights and Forecast, 2018-2026,” the global market is likely to reach US$ 4,612.1 Mn by 2026 owing to the rising incidence of autism spectrum disorder worldwide. The report provides valuable insights into the global market trends and factors that are directly affecting the growth of the market. As per the report, the global autism spectrum disorder therapeutics market was worth US$ 3,293.0 Mn in 2018. Considering the increasing awareness programs regarding this particular disorder and less availability of treatment options, the global market is expected to rise at a moderate CAGR of 4.3% during the forecast period (2019-2026).

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/autism-spectrum-disorder-therapeutics-market-101207

Key Players Operating in The Autism Spectrum Disorder Therapeutics Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Applied Behavior Consultants,
• Allergan,
• Pfizer Inc.,
• Q BioMed Inc,
• Fusion Autism Center,
• AstraZeneca,
• Hopebridge, LLC.,
• Johnson & Johnson Services, Inc.,
• Behavior Innovations,
• Eli Lilly and Company,
• Otsuka Holdings Co. Ltd.,
• other prominent market players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/autism-spectrum-disorder-therapeutics-market-101207

Highlights of the Report:

• In-depth analysis of various insights, namely, Autism Spectrum Disorder Therapeutics Market trends, growth drivers, opportunities, and other related challenges.
• Comprehensive details of key market players, their core competencies, and Autism Spectrum Disorder Therapeutics Market share.
• The potency of suppliers and buyers to make better business decisions.
• Lists out the market size in terms of volume.

Autistic Disorder Segment to Witness Growth Owing to the Rising Prevalence of the Disease

The global autism spectrum disorder therapeutics market is grouped into drug therapy and communication and behavioral therapy in terms of treatment type. Amongst these, the communication and behavioral therapy segment was in the leading position in the global market. Fortune Business Insights predicts that it will retain its position throughout the forecast period. In terms of type, the autism spectrum disorder therapeutics market is classified into Asperger syndrome, autistic disorder, pervasive development disorder, and others. Out of these, the autistic disorder segment procured the highest autism spectrum disorder therapeutics market share in the year 2018. It is anticipated to witness significant growth in the coming years. This growth is attributed to the increasing prevalence of this disorder.

Reasons to Purchase this Report:

• Comprehensive analysis of the Autism Spectrum Disorder Therapeutics Market growth drivers, obstacles, opportunities, and other related challenges.
• Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
• Identifies market restraints and boosters.
• Identifies all the possible segments present in the market to aid organizations in strategic business planning.

The global “contraceptive pills market” size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market. Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs. The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas. To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace. This will effectively accelerate the oral contraceptives market growth during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802

Leading Players operating in the Contraceptive Pills Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Janssen Pharmaceutical Company
• Piramal Enterprises
• Allergan, plc
• Mylan N.V.
• Pfizer, Inc.
• Bayer AG
• Teva Pharmaceutical Industries
• HLL Lifecare Limited
• Merck & Co., Inc.
• others

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contraceptive-pills-market-101802

Increasing Popularity of Advanced Contraceptives to Propel the Market in North America

North America is slated to dominate the contraceptive pills market share, since the region generated USD 4.09 billion in revenue in 2018. The primary reason for this is the rising uptake of short-acting reversible contraceptives in the U.S. and patient-friendly reimbursement policies for oral birth-control pills. Europe will emerge as the second leading region in this market, led by France which has the highest birth rate in the region. Better reimbursement policies will also bode well for the market in Europe. Asia-Pacific will record the fastest growth owing to rising number of awareness drives conducted by the government and NGOs. In Latin America, the Middle East, and Africa, increasing presence of big pharmaceutical companies and growing literacy rates will drive the market in these regions. 

Market Segmentation:

By Type

• Combines Contraceptives Pills
• Progestin-only Pills

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Channel
• Public Channel & NGOs
• Others

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia-Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East and Africa ( South Africa, GCC, and Rest of Middle East & Africa)

Exciting Opportunities Await Local and Regional Players in the Market

While big companies such as Bayer AG are benefiting owing to their well-established presence, smaller players operating at the local and regional level are also slowly gaining ground in this market. This is a result of launching of innovative products by these players along with certain capacity restrictions hounding the large players.

Key Industry Developments:

• December 2019: A team of scientists from the Massachusetts Institute of Technology (MIT) developed a contraceptive pill that needs to be taken only once a month. It is a gelatin capsule that releases synthetic hormones in the stomach, preventing unwanted pregnancy.
• August 2017: Lupin Pharmaceuticals voluntarily recalled its contraceptive Mibelas 24 FE from the market in the U.S. as they were purportedly out of sequence.

The Global Mass Spectrometer Market is likely to expand at a CAGR of 7.8% between 2019 and 2026. Fortune Business Insights in a report, titled “MASS SPECTROMETER: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026” predicts that the adoption of mass spectrometer equipment is likely to increase as this equipment can precisely measure the molecular weight of an analyst. The mass spectrometer instrument together with chromatography calculates the analytical mass of a particular molecule. The report predicts the Global Mass Spectrometer Market was valued at US$ 5,512.2 Mn in the year 2018 and is anticipated to reach US$ 10,044.7 Mn by 2026.

Leading Players operating in the Mass Spectrometer Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Shimadzu Corporation
• PerkinElmer Inc.
• WATERS
• Thermo Fisher Scientific Inc.
• Bruker
• AB Sciex
• Agilent Technology
• LECO
• JEOL USA
• Advion, Inc.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Market Please visit: https://www.fortunebusinessinsights.com/industry-reports/mass-spectrometer-market-101068

Segmentation

By Product

• Hybrid
• Tandem Quadrupole
• Quadrupole Time-of-Flight (Q-TOF)
• FTMS
• Single
• Single Quadrupole
• Time-of-Flight (TOF)
• Ion Trap

By End-user

• Biopharmaceutical and Pharmaceutical Companies
• Research Institutes & Government Organization
• Hospitals & Diagnostic Centers
• Others (Environmental testing, food, and chemical testing)

By Geography

• North America (the USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Rest of World

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/mass-spectrometer-market-101068

Market in North America Continues to Lead Owing to Presence of Key Players in the U.S.

Among regions, the market in North America is expected to maintain its dominance through the forecast period. Moreover, the regional market was valued at US$ 2,126.7 Mn in the year 2018. Presence of recognized key players and technological advancements are creating lucrative opportunities for the market. Governments in this region are granting funds to research institutes working on in mass spectrometry, which will further increase the mass spectrometer market share in North America. The University of Georgia recently received grants from the National Institutes of Health in the U.S. This funding is for conducting biomedical research and this is another factor responsible for the high growth of the market in this region. A report by the Industrial Research Institute (IRI) finds that the U.S. is the only country in the world who spends aggressively on research and development activities. Governments in North America are increasingly investing in areas such as biomedical, biotechnology, and proteomics. Such factors are likely to accelerate the mass spectrometer market size in North America. 

The global prevalence of primary immunodeficiency is rising, giving impetus to the global “intravenous immunoglobulins market”. A report is published by Fortune Business Insights, titled “INTRAVENOUS IMMUNOGLOBULINS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2018-2025,” offers in-depth insights into the market. As per the report, in 2017 the global market was worth US$ 9,787.6 Mn. The market is anticipated to further expand at a CAGR of 6.2% and reach US$ 15,789.1 by the end of 2025. In terms of indication, the report classifies the global market in primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy (CIDP), and others. Primary immunodeficiency was leading the market in 2017. The segment accounted for 28.6% of the global market in 2017. During the forecast period 2018-2025, the segment is likely to witness expansion at an impressive pace.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/intravenous-immunoglobulins-market-100593

Key Players Operating in The Intravenous Immunoglobulins Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• CSL Behring
• Grifols
• A.
• Kedrion S.p.A
• Octapharma
• Bio Products Laboratory Ltd.
• Biotest AG
• China Biologic Products Holdings, Inc.
• LFB SA
• Shanghai RAAS Blood Products Co., Ltd.

Highlights of the Report:

• In-depth analysis of various insights, namely, Intravenous Immunoglobulins Market trends, growth drivers, opportunities, and other related challenges.
• Comprehensive details of key market players, their core competencies, and Intravenous Immunoglobulins Market share.
• The potency of suppliers and buyers to make better business decisions.
• Lists out the market size in terms of volume.
• Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593

Intravenous Immunoglobulin Application in Hospitals to Rise Persistently

Intravenous immunoglobulin is the most common route of administration of immunoglobulins, which is the chief driver of the global market. The rising demand from hospitals and specialty clinics is anticipated to encourage the adoption of intravenous immunoglobulins. Furthermore, key companies are increasingly investing in research and development of advanced intravenous immunoglobulins. Such researches are likely to enable growth in the market over the forecast period. Immunoglobulins are proven to be one of the best treatment options for various immune diseases. Owing to the high popularity of immunoglobulins, the market is foreseen to witness high demand.

North America to Continue Dominating Global Market

The North America intravenous immunoglobulins market was worth US$ 5,587.4 Mn in 2017. The region is further expected to emerge dominant over the forecast period. The increasing number of patients in the region is anticipated to drive the regional market. Moreover, in terms of dominance of route of administration, intravenous (IV) is the most dominating type in developing nations. This is likely to enable growth in market. Besides this, the advanced intravenous immunoglobulins are being rapidly adopted in developed nations. This in response is fueling the demand in market. Asia Pacific is anticipated to expand at a promising CAGR. Owing to the high prevalence of primary immunodeficiency in Asian population, the market is foreseen to witness demand for immunoglobulin.

The global genomics market size is projected to reach USD 62614.6 million by 2026. Genomics has successfully transformed the way of preventing, managing and treating diseases. Researchers at the University of Paris-Saclay believe that we have entered into the third revolution of sequencing technology in the world of genetics. Moreover, several companies are planning to build third-generation sequencing technology to stay abreast of new trends. As per a recent report published by Fortune Business Insights, titled “Genomics Market Size, Share and Industry Analysis By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing), Application (Diagnostics, Research), End-User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs)) & Regional Forecast, 2019 – 2026,” the market value stood at USD 15888.8 million in 2018 and is anticipated to exhibit an exponential CAGR of 18.7% during the forecast period.

Leading Players operating in the Genomics Market are:

• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies
• Danaher
• QIAGEN
• BGI
• IntegraGen

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

The genomics market report outlines the present and future scenario of the market by offering key insights into the trends and drivers stimulating growth. Furthermore, it highlights detailed information on several aspects of the market which include opportunities, challenges, and threats. The report throws lights on the competitive landscape by covering key developments of some of the leading players. It also highlights strategies adopted by players, which in turn, can help stakeholders to make business decisions. Further to this, it also showcases information on all the major segments and their respective market share.

Helix’s New DNA Studio to Aid in Expansion of the Market

Genomics has proved to be successful in the diagnosis of chronic diseases such as cancer. Owing to the increasing prevalence of cancer around the world, the demand for genomics products and services is expected to increase in the forthcoming years. As per the recent genomics market trends, product segment is expected to lead the market in the forecast years. The growth is attributable to the rising use of consumables and increasing number of product launches. For instance, a personal genomics company called Helix announced the launch of a new DNA product studio in October 2018. The aim of this launch is to build and distribute DNA products, thereby benefitting hundreds and thousands of people who want to know how DNA plays a crucial role in wellness and health.

A lead analyst at Fortune Business Insights stated that services segment is estimated to gain immense popularity. He further added that the rising demand for next-generation sequencing services along with cost-effective sequencing services will encourage patients to adopt genomics services.

Request a Sample Copy of the Global Genomics Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941

Advancements in Bioinformatics to Boost the Market in North America

Among regions, North America is anticipated to emerge dominant in the global genomics market throughout the forecast years. In 2018, the market value stood at USD 6959.3 million. This is ascribable to the rising focus on pharmacogenomics and technological advancements in bioinformatics. This, coupled with increasing adoption of new sequencing technologies, will create growth opportunities for the market in this region. Rising preference for personalized medicines is another factor responsible for the dominance of market in this region.

Apart from North America, the market in Europe is expected to exhibit a higher CAGR owing to the robust support from governments, especially in the U.K. Asia Pacific is expected to hold a considerable genomics market share over the projected horizon. Factors such as increasing the aging population, high demand for genetic sequencing in China, and expansion of healthcare system are positively impacting the genomics market growth in this region.

The global “Pressure Ulcer Treatment Market Size” is expected to gain momentum from the rising adoption of innovative wound care devices for treatment. As per the Agency for Healthcare Research & Quality (AHRQ), in the U.S., more than 2.5 million people get affected by pressure ulcers annually. It proves that the increasing geriatric population, coupled with upsurging cases of PU would affect the market positively in the coming years.

This information is provided by Fortune Business Insights™ in a recent study, titled, “Pressure Ulcer (PU) Treatment Market Size, Share & Industry Analysis, By Ulcer Type (Stage 1, Stage 2, Stage 3, Stage 4), By Product (Wound-care Dressings, Wound-care Devices, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2019-2026.” The study further states that the pressure ulcer treatment market size is projected to reach USD 11.23 billion by 2026, thereby exhibiting a CAGR of 6.7% during the forecast period. However, it stood at USD 6.69 billion in 2018.

The report covers:

• Global Pressure Ulcer Treatment Markettrends, with detailed analysis on consumer trends & manufacturer trends.
• Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
• Key areas of investments identifying market opportunities and challenges in forecast timeframe.
• Competitive analysis of the industry players along with the overview on strategic management.
• Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pressure-ulcer-treatment-market-102095

Leading Players operating in the Pressure Ulcer Treatment Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Cardinal Health
• Braun Melsungen AG
• Braun Melsungen AG
• Coloplast Corp
• Tissue Regenix Group
• Smith & Nephew
• ConvaTec Group Plc
• Integra LifeSciences Corporation
• 3M
• Other prominent players

Rising Patent Pool Worldwide to Augment Growth

In the 20th century, a pressure ulcer was considered to be one of the costliest and the most physically debilitating complications. Factors, such as mobility problems, sedentary lifestyle, advancing age, and other similar health issues are mainly responsible for surging the incidence of PU worldwide. The National Center for Biotechnology Information (NCBI) declared that in 2018, the prevalence of pressure ulcers in Ethiopia, Turkey, and Brazil was 16%, 10.4%, and 12.7%, respectively. This indicates that there is a large patient pool seeking medical help across the globe.

Wound Care Dressings Segment to Lead Owing to their Higher Adoption

In terms of product type, the market is divided into wound care dressings, wound care devices, and others. Amongst these, the wound care dressings segment held 64.9% PU treatment market share in 2018 and is set to lead throughout the forecast period. This growth is attributable to their increasing adoption amongst the masses. They are the primary treatment option and help in speeding up the healing process.

The global compression therapy market size is projected to reach USD 4.51 billion by 2026, exhibiting a CAGR of 5.2% during the forecast period. Rising prevalence of cancer will be a key growth driver for this market in the coming decade, finds Fortune Business Insights™ in its report, titled “Compression Therapy Market Size, Share and Industry Analysis By Product (Compression Garments {Compression Bandages, Compression Stockings, and Others}, Compression Pumps, and Others), By Application (Venous Leg Ulcer, Deep Vein Thrombosis (DVT), Lymphedema, and Others), By End User (Hospitals & Clinics, Nursing Care Centers, Home Care, and Others), and Regional Forecast, 2019-2026”. The global disease burden of cancer, according to the International Agency for Research on Cancer (IARC), rose by an estimated 18.1 million new cases in 2018.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/compression-therapy-market-102689

List of Top Players Covered in the Report:

• Tactile Systems Technology, Inc.
• Smith & Nephew
• medi GmbH & Co. KG
• Arjo
• SIGVARIS
• Bio Compression Systems, Inc.
• EssityAktiebolag (publ)
• PAUL HARTMANN Pty. Ltd
• 3M

Cancer therapy, especially for breast and prostate cancers, generally involves dissection of lymph nodes, which causes disruption in the filtering mechanism of the lymphatic system in the body. As a result, lymph fluid accumulates and causes massive swelling of limbs or tissues, a condition known as lymphedema. Worldwide prevalence of this condition, as reported by the National Institutes of Health, is around 250 million. One of the most commonly used treatment options for lymphedema is compression therapy and with increasing incidence of this condition, the demand for these therapies is set to steadily rise.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/compression-therapy-market-102689

The compression therapy market report states that the value of the market was at USD 3.01 billion in 2018. Other highlights of the report include:

• Precise computation of market figures and values;
• Elaborative overview of the overall industry outlook;
• Exhaustive analysis of the key market drivers, trends, and restraints;
• Detailed segmentation of the market and comprehensive study of all segments; and
• In-depth research into the regional milieu and competitive developments in the market.

Market Driver

Increasing Geriatric Population to Stoke Growth

The world population is aging at an astonishing rate. Demographic analysis of the UN Department of Economic and Social Affairs (DESA) suggests that by 2050, the number of people aged 60 years and above is set to double, reaching 2.1 billion. Aging entails a host of health problems and vein disorders are some of the most common ailments that inflict older people. For example, old age is a high risk factor for varicose veins as the wear & tear of valves in the veins causes the blood to flow back into the veins instead flowing towards the heart. Similarly, the incidence of deep vein thrombosis is high among the geriatric population due to reduced physical movement. Thus, expanding aging population worldwide is expected to be a major demand-puller for compression therapies, thereby augmenting the compression treatment market growth.

The global medical clothing market is set to gain momentum from the rising incidence of hospital-acquired infections. Besides, the rising awareness campaigns regarding the benefits of clinical clothing would affect the market positively. Fortune Business Insights™ provided this information in a recent report, titled, “Medical Clothing Market Size, Share & Industry Analysis, By Product (Surgical Drapes, Medical Scrubs and Gowns, Gloves, Facial Protection, Sterilization Wraps, Protective Apparels and Others), By Application (Hospitals & Physicians’ Offices, Outpatient Facilities, and Others), and Regional Forecast, 2020-2027.” The report further states that the medical clothing market size was USD 63.3 billion in 2019 and is projected to reach USD 99.9 billion by 2027, exhibiting a CAGR of 5.9% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/medical-clothing-market-102704

Fortune Business Insights™ lists out the names of organizations present in the global market. They are as follows:

• Cardinal Health, Inc.
• Halyard Health
• 3M Company
• Medline Industries, Inc.
• Superior Uniform Groups
• Semperit AG Holding
• Ansell Healthcare LLC
• Medline Industries
• Mölnlycke Health Care
• Barco Uniforms
• Other prominent players

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/medical-clothing-market-102704

Please visit:

Highlights of the Report

• Analysis of the impact of Covid-19 that the market would face in the near future.
• In-depth analysis of the growth drivers and obstacles.
• Profile of all the companies operating in the market.
• Elaborate data about the dominating region.
• Competitive landscape consisting of mergers & acquisitions, investments, partnerships, new product launches, opening of new facilities, and new contracts.

Drivers & Restraints-

Outbreak of Covid-19 Pandemic to Surge Demand for Medical Clothing

In January 2020, the World Health Organization (WHO) declared that the outbreak of Covid-19 pandemic occurred because of coronavirus. The virus is anticipated to have its origin in snakes or bats. The WHO also tagged Covid-19 as a Public Health Emergency of International Concern (PHEIC). The Centers for diseases control and Prevention (CDC) mentioned that among all the emerging infectious disease that affect humans, around 75% of them originate from animals. Hence, the increasing concerns regarding infectious diseases are likely to boost the medical clothing market growth in the coming years. Besides, zoonotic diseases have a tendency to affect public health worldwide, especially the emerging countries owing to their lack of control strategies. However, medical clothing often has to be approved by the regulatory bodies, such as the FDA. It involved extra expenses. Therefore, it may hinder the market growth.